Target arm affinities determine preclinical efficacy and safety of anti-HER2/CD3 bispecific antibody.
Jci Insight
Staflin, Karin K; Zuch de Zafra, Christina L CL; Schutt, Leah K LK; Clark, Vanessa V; Zhong, Fiona F; Hristopoulos, Maria M; Clark, Robyn R; Li, Ji J; Mathieu, Mary M; Chen, Xiaocheng X; Johnston, Jennifer J; Low, Justin J; Ybarra, Ryan R; Slaga, Dionysos D; Yang, Jihong J; Ovacik, Meric M; Dybdal, Noël O NO; Totpal, Klara K; Junttila, Melissa R MR; Ellerman, Diego D; Lee, Genee G; Dennis, Mark S MS; Prell, Rodney R; Junttila, Teemu T TT